Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Discovery Life Sciences™ has acquired the Gentest® business unit, part of Corning Incorporated's Life Sciences business. The acquisition of Gentest complements Discovery's recent acquisition of In Vitro ADMET Laboratories, LLC (IVAL) in December of ...
read more
Dipharma Francis S.r.l. announced that the Italian Medicines Agency (AIFA) approved the brand-new production line at the cGMP pilot plant suite, located in its facility of Mereto di Tomba (Italy).
read more
Monday, February 24, 2020
Dipharma Francis announced the completion of the new cGMP Quality Control laboratory and c-GMP kilolab at its CDMO site located in Kalamazoo MI.
read more
DFE Pharma, a global leader in pharmaceutical excipient solutions, is excited to announce the launch of a new addition to its broad excipient portfolio, Pharmacel® sMCC 90, a silicified microcrystalline cellulose (MCC).
read more
DFE Pharma, a global leader in pharmaceutical excipient solutions, is proud to announce its collaboration with AJM Pharma as a key supplier with BioHale® Sucrose to support COVID-19 vaccine supply challenges in Pakistan.
read more
DFE Pharma, a global leader in pharma-, biopharma-and nutraceutical excipient solutions, has appointed Marie-Louise Mans as Global Human Resources (HR) Director, joining as a member of the Leadership Team. DFE Pharma, headquartered in Goch, Germany, ...
read more
Devonian and Histapharm announced they have signed a binding LOI to negotiate the terms establishing Devonian as the exclusive site for manufacturing of Histapharm’s proprietary botanical drug.
read more
Wednesday, October 16, 2019
Delpharm and Famar have entered into exclusive negotiations for the acquisition by Delpharm of five Famar manufacturing sites in France, the Netherlands and Canada.
read more
DefiniGEN has identified iPSC-derived intestinal organoids that could be used to help structure in vitro studies of the biology of SARS-CoV2 infection across cohorts of multiple patients.
read more
Tuesday, February 09, 2021
Catalent has signed an agreement to provide Decibel Therapeutics with process and analytical development, and CGMP clinical manufacturing services, for Decibel’s lead investigational gene therapy product candidate, DB-OTO.
read more
Debiopharm and Ipsen announced renewal of their Decapeptyl® agreement, which extends their partnership through 2034 for the development, manufacturing and distribution of Decapeptyl®.
read more
Particle Sciences has broadened its Drug Enforcement Administration (DEA) registration to become an authorized manufacturer of Schedule I substances.
read more
DCPrime BV and apceth Biopharma GmbH announced they have entered into a strategic manufacturing agreement.
read more
Out of an abundance of caution, and with a rapidly growing number of our participants not being able to travel, we’ve made the difficult decision to cancel DCAT Week 2020.
read more
Dante Labs, Cambridge Cancer Genomics, and Nonacus, a provider of genetic testing products for precision medicine and liquid biopsy, have signed a collaboration agreement.
read more